Seebri and Breo ellipta drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Seebri (glycopyrrolate) and Breo ellipta (fluticasone furoate; vilanterol trifenatate). Common drug interactions include dysphonia among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Seebri and Breo ellipta. It is created by eHealthMe based on reports of 164 people who take the same drugs from the FDA, and is updated regularly.
What is Seebri?
Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.
What is Breo ellipta?
Breo ellipta has active ingredients of fluticasone furoate; vilanterol trifenatate. It is often used in asthma. eHealthMe is studying from 37,362 Breo ellipta users. Check the latest studies of Breo ellipta.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
164 people who take Seebri and Breo ellipta together, and have interactions are studied.
What are the common drug interactions of Seebri and Breo ellipta, by gender? *
What are the common drug interactions of Seebri and Breo ellipta, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Seebri and Breo ellipta?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Seebri (2,618 reports)
- Breo ellipta (37,362 reports)
Browse all drug interactions of Seebri and Breo ellipta:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Seebri:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Breo ellipta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Seebri and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Breo ellipta and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
- D'souza S, Gowler V, "Glycopyrrolate‐induced respiratory arrest: an unusual side effect", Acta Anaesthesiologica Scandinavica, 2015 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on glycopyrrolate and fluticasone furoate; vilanterol trifenatate (the active ingredients of Seebri and Breo ellipta, respectively), and Seebri and Breo ellipta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Linzess cause Mania? - 11 seconds ago
- Ortho Tri-Cyclen Lo vs. Levonorgestrel, side effect and effectiveness comparison - 15 seconds ago
- Could Losartan cause Basal Cell Carcinoma? - 56 seconds ago
- Braftovi and Rhabdomyolysis for Men aged 60+ - a minute ago
- Lortab vs. Profen, side effect and effectiveness comparison - a minute ago
- Neurontin vs. Cymbalta, side effect and effectiveness comparison - a minute ago
- Could Lexapro cause White Blood Cell Count Abnormal? - 2 minutes ago
- Could Pulmicort cause Paraesthesia? - 2 minutes ago
- Eliquis and Cardiomegaly for Men aged 60+ - 2 minutes ago
- Eliquis and Enlarged Heart for Men aged 60+ - 2 minutes ago